Диссертация (1140518), страница 23
Текст из файла (страница 23)
Brown,D.H. Mitchell [et al.] // Proc (Bayl Univ Med Cent). – 2001. – Vol.14. – №1. – Р.13-21.117.Ghodki, P.S. Dexmedetomidine as an anesthetic adjuvant in laparoscopic surgery: Anobservational study using entropy monitoring / P.S. Ghodki, S.K. Thombre, S.P.
Sardesai [et al.] // JAnaesthesiol Clin Pharmacol. – 2012. – Vol.28. – №3. – Р.334-8.118.Gogus, N. The comparison of the effects of dexmedetomidine, fentanyl and esmolol onprevention of hemodynamic response to intubation / N. Gogus, B. Akan, N.
Serger [et al.] // Braz JAnesthesiol. – 2014. – Vol.64. – №5. – Р.314-9.119.Gonullu, E. Comparison of the effects of dexmedetomidine administered at two differenttimes on renal ischemia/reperfusion injury in rats / E. Gonullu, S. Ozkardesler, T. Kume [et al.] //Braz J Anesthesiol. – 2014. – Vol.64. – №3. – Р.152-8.105120.Goyagi, T.
Oral clonidine premedication reduces induction dose and prolongs awakeningtime from propofol-nitrous oxide anesthesia / T. Goyagi, M. Tanaka, T. Nishikawa // Can J Anaesth.– 1999. – Vol.46. – №9. – Р.894-6.121.Grewal, A. Dexmedetomidine: New avenues / A. Grewal // J Anaesthesiol Clin Pharmacol.– 2011. – Vol.27. – №3. – Р.297-302.122.Gu, J. Dexmedetomidine provides renoprotection against ischemia-reperfu sion injury inmice / J. Gu, P.
Sun, H. Zhao [et al.] // Crit Care. – 2011. – Vol.15. – №3. – R153.123.Gulabani, M. Comparative analysis of efficacy of lignocaine 1.5 mg/kg and two differentdoses of dexmedetomidine (0.5 μg/kg and 1 μg/kg) in attenuating the hemodynamic pressure responseto laryngoscopy and intubation / M. Gulabani, P. Gurha, P. Dass [et al.] // Anesth Essays Res. – 2015.– Vol.9.
– №1. – P.5-14.124.Guneli, E. Analysis of the antinociceptive effect of systemic administration of tramadoland dexmedetomidine combination on rat models of acute and neuropathic pain / E. Guneli, N.U.Karabay Yavasoglu, S. Apaydin [et al.] // Pharmacol Biochem Behav. – 2007. – Vol.88. – №1. – Р.917.125.Guo, T.Z. Nitrous oxide produces antinociceptive response via alpha2B and/or alpha2Cadrenoceptor subtypes in mice / T.Z. Guo, M.F. Davies, W.S.
Kingery [et al.] // Anesthesiology. –1999. – Vol.90. – №2. – Р.470–6.126.Hall, J.E. Sedative, analgesic and cognitive effects of clonidine infusions in humans / J.E.Hall, T.D. Uhrich, T.J. Ebert // Br J Anaesth. – 2001. – Vol.86. – №1. – Р.5-11.127.Hoffman, W.E. Dexmedetomidine improves neurologic outcome from incompleteischemia in the rat: reversal by the α2-adrenergic antagonist atipamezole / W.E. Hoffman, E.
Kochs,C. Werner [et al.] // Anesthesiology. – 1991. – Vol.75. – №2. – Р.328-32.128.Honore, P. To what extent do spinal interactions between an alpha-2 adrenoceptor agonistand a mu- opioid agonist influence noxiously evoked c-Fos expression in the rat? A pharmacologicalstudy / P. Honore, V. Chapman, J. Buritova [et al.] // J Pharmacol Exp Ther. – 1996. – Vol.278. –№1. – Р.393– 403.129.Housmans, P.R. Effects of dexmedetomidine on contractility, relaxation, and intracellularcalcium transients of isolated ventricular myocardium / Housmans P.R. // Anesthesiology. – 1990.
–Vol.73. – №5. – P.919-22.130.Huang, L.Y. Ca2+-dependent exocytosis in the somata of dorsal root ganglion neurons /L.Y. Huang, E. Neher // Neuron. – 1996. – Vol.17. – №1. – Р.135–45.106131.Huang, Y. Perineural dexmedetomidine attenuates inflammation in rat sciatic nerve via theNF-κB pathway / Y. Huang, Y. Lu, L. Zhang [et al.] // Int J Mol Sci.
– 2014. – Vol.15. – №3. –Р.4049-59.132.Hylden, J.L. Pharmacological characterization of Substance P-induced nociception inmice: modulation by opioid and noradrenergic agonists at the spinal level / J.L. Hylden, G.L.Wilcox// J Pharmacol Exp Ther. – 1983. – Vol.226. – №2. – Р.398–404.133.Ishikawa, S. Hemodynamic effects of dexmedetomidine in patients after cardiac surgery /S.
Ishikawa, S. Kugawa, K. Neya [et al.] // Minerva Chir. – 2006. – Vol.61. – №3. – P.215–9.134.Jasmin, L. Rostral agranular insular cortex and pain areas of the central nervous system: atract-tracing study in the rat / L. Jasmin, A.R. Burkey, A. Granato [et al.] // J Comp Neurol. – 2004.– Vol.480. – №3. – Р.330.135.Jasmin, L.
The NK1 receptor mediates both the hyperalgesia and the resistance to morphinein mice lacking noradrenaline / L. Jasmin, D. Tien, D. Weinshenker [et al.] // Proc Natl Acad SciUSA. – 2002. – Vol.99. – №2. – Р.1029–34.136.Ji, F. Perioperative dexmedetomidine improves outcomes of cardiac surgery / F. Ji, Z. Li,H. Nguyen [et al.] // Circulation. – 2013.
– Vol.127. – №15. – Р.1576-84.137.Kabalak,A.Thesynergisticantinociceptiveinteractionsofmorphineanddexmedetomidine in rats with nerve-ligation injury / A. Kabalak, E. Ekmekçioğlu, A. Ceylan [et al.]// Hippokratia. – 2013. – Vol.17. – №4. – Р.326-31.138.Kabukçu, H.K. Hemodynamics in coronary artery bypass surgery: effects of intraoperativedexmedetomidine administration / H.K. Kabukçu, N.
Sahin, Y. Temel [et al.] // Anaesthesist. – 2011.– Vol.60. – №5. – Р.427-31.139.Kamibayashi, T. Clinical uses of a2 adrenergic agonists / T. Kamibayashi, M. Maze //Anesthesiology. – 2000. – Vol.93. – №5. – Р.1345–9.140.Kastner, S.B. Comparative pharmacokinetics of medetomidine enantiomers in goat andsheep during sevoflurane anaesthesia / S.B. Kastner, S.M. Pakarinen, M.P. Ramela [et al.] // J. Vet.Pharm.
Ther. – 2006. – Vol.29. – №1. – P.63-6.141.Katz, J. Pre-emptive analgesia: evidence, current status and future directions / J. Katz //Eur J Anaesthesiol Suppl. – 1995. – Vol.10. – P.8-13.142.Katz, J. Preventive аnalgesia: quo vadimus? / J. Katz, H. Clarke, Z. Seltzer // Anesth Analg.– 2011. – Vol.113. – №5. – P.1242-53.143.Kauppila, T. Effect of systemic medetomidine, an alpha 2 adrenoceptor agonist, onexperimental pain in humans / T. Kauppila, P. Kemppainen, H. Tanila [et al.] // Anesthesiology. –1991. – Vol.74.
– №1. – Р.3–8.107144.Kawasaki, Y. Alpha-2 Adrenoceptor-mediated presynaptic inhibition of primary afferentglutamatergic transmission in rat substantia gelatinosa neurons / Y. Kawasaki, E. Kumamoto, H.Furue [et al.] // Anesthesiology. – 2003. – Vol.98. – №3. – Р.682–9.145.Kehlet, H. Evidence-based surgical care and the evolution of fast-track surgery / H. Kehlet,D.W.
Wilmore // Ann Surg. – 2008. – Vol.248. – №2. – P.189-198.146.Khan, Z.P. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers.1: Pharmacodynamic and pharmacokinetic interactions / Z.P. Khan, I.T. Munday, R.M. Jones [et al.]// Br J Anaesth. – 1999. – Vol.83. – №3. – Р.372-80.147.Kivisto, K.T. Pharmacokinetics and pharmacodynamics of transdermal dexmedetomidine/ K.T.
Kivisto, A. Kallio, P.J. Neuvonen // Eur J Clin Pharmacol. – 1994. – Vol.46. – №4. – Р.345–9.148.Kodera, S.Y. Inhibition of insulin secretion from rat pancreatic islets by dexmedetomidineand medetomidine, two sedatives frequently used in clinical settings / S.Y. Kodera, M. Yoshida, K.Dezaki [et al.] // Endocr J.
– 2013. – Vol.60. – №3. – Р.337-46.149.Korogulu, A. Sedative, haemodynamic and respiratory effects of dexmedetomidine inchildren undergoing magnetic resonance imaging examination: preliminary results / A. Korogulu, S.Demirbilek, H. Teksan [et al.] // Br J Anaesth. – 2005. – Vol.94. – №6. – Р.821–4.150.Kuraishi, Y. Noradrenaline regulation of pain-transmission in the spinal cord mediated byalpha-adrenoceptors / Y. Kuraishi, Y. Harada, H. Takagi // Brain Res. – 1979. – Vol.174. – №2. –Р.333-6.151.Kwiat, G.C. The origin of brainstem noradrenergic and serotoninergic projections to thespinal cord dorsal horn in the rat / G.C. Kwiat, A.I.
Basbaum // Somatosens Mot Res. – 1992. – Vol.9.– №2. – Р.157–73.152.Kyles, A.E. The spinal antinociceptive activity of the alpha 2-adrenoceptor agonist,xylazine in sheep / A.E. Kyles, A.E. Waterman, A. Livingston // Br J Pharmacol. – 1993. – Vol.108.– №4. – Р.907-13.153.Kаstner, S.B.
Comparison of cardiopulmonary effects of dexmedetomidine administeredas a constant rate infusion without loading dose in sheep and goats anaesthetised with sevoflurane /S.B. Kаstner, J. Boller, A.P. Kutter [et al.] // Small ruminant research. – 2007. – Vol.71. – №1. –P.75–82.154.Landoni, G. Randomized evidence for reduction of perioperative mortality / G. Landoni,R.N.
Rodseth, F. Santini [et al.] // J Cardiothorac Vasc Anesth. – 2012. – Vol.26. – №5. – Р.764-72.108155.Larsen, J.F. Randomized clinical trial of the effect of pneumoperitoneum on cardiacfunction and haemodynamics during laparoscopic cholecystectomy / J.F. Larsen, F.M. Svendsen, V.Pedersen // Br J Surg. – 2004. – Vol.91. – №7. – P.848-54.156.Lawrence, C.J. Hemodynamic and coronary vascular effects of dexmedetomidine inanesthetized goats / C.J.
Lawrence, F.W. Prinzen, S. DeLange // Acta Anaesth. Scand. – 1997. –Vol.41. – №7. – P.830-6.157.Lee, C. Antihyperalgesic effects of dexmedetomidine on high-dose remifentanil-inducedhyperalgesia / C. Lee, Y.D. Kim, J.N Kim // Korean J Anesthesiol. – 2013. – Vol.64. – №4. – Р.3017.158.Lee, K. Assessment of dexmedetomidine effects on left ventricular function using pressure-volume loops in rats / K. Lee, H.J. Hwang, O.S. Kim [et al.] // J Anesth. – 2017. – Vol.31. – №1. –Р.18-24.159.Lee, M. A comprehensive review of opioid-induced hyperalgesia / M. Lee, S.M.Silverman, H. Hansen [et al.] // Pain Physician.
– 2011. – Vol.14. – №2. – P.145-61.160.Li, A. Pharmacokinetics and pharmacodynamics of dexmedetomidine / A. Li, V.M. Yuen,S. Goulay-Dufay [et al.] // Drug Dev Ind Pharm. – 2016. – Vol.42. – №12. – Р.1917-27.161.Li, G. Epidemiology of anesthesia-related mortality in the United States 1999–2005 / G.Li, M. Warner, B.H. Lang [et al.] // Anesthesiology. – 2009. – Vol.110. – №4. – Р.759–65.162.Liang, X. Efficacy of dexmedetomidine on postoperative nausea and vomiting: a meta-analysis of randomized controlled trials / X. Liang, M. Zhou, J.J. Feng [et al.] // Int J Clin Exp Med.– 2015.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
